Inviragen and Singapore's SingVax combine operations
This article was originally published in Scrip
Executive Summary
Two small privately held vaccines companies, Inviragen of the US and Singapore's SingVax, have merged to create an enlarged operation with a focus on vaccines for infectious diseases prevalent in developing countries.